BioXcel Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Rodriguez Javier | See Remarks | Option Exercise | 33 | — | — | 6,760 | Dec 15, 2025 |
| Mehta Vimal | CEO and President | Option Exercise | 219 | — | — | 20,876 | Dec 14, 2025 |
| Steinhart Richard I | Chief Financial Officer | Option Exercise | 35 | — | — | 6,577 | Dec 14, 2025 |
| Yocca Frank | Chief Scientific Officer | Option Exercise | 35 | — | — | 6,452 | Dec 14, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,694 | — | — | 20,317 | Oct 31, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,694 | — | — | 18,623 | Sep 30, 2025 |
| Mehta Vimal | CEO and President | Option Exercise | 163 | — | — | 20,274 | Sep 15, 2025 |
| Steinhart Richard I | Chief Financial Officer | Option Exercise | 33 | — | — | 6,474 | Sep 15, 2025 |
| Rodriguez Javier | See Remarks | Option Exercise | 35 | — | — | 6,727 | Sep 14, 2025 |
| Yocca Frank | Chief Scientific Officer | Option Exercise | 35 | — | — | 6,384 | Sep 14, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 16,930 | Aug 31, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 15,237 | Jul 31, 2025 |
| Mehta Vimal | CEO and President | Award / Grant | 15,625 | — | — | 20,111 | Jul 22, 2025 |
| Yocca Frank | Chief Scientific Officer | Award / Grant | 4,375 | — | — | 6,316 | Jul 22, 2025 |
| Steinhart Richard I | Chief Financial Officer | Option Exercise | 625 | — | — | 6,441 | Jul 22, 2025 |
| Rodriguez Javier | See Remarks | Award / Grant | 4,375 | — | — | 6,034 | Jul 22, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 13,544 | Jun 30, 2025 |
| Steinhart Richard I | Chief Financial Officer | Option Exercise | 33 | — | — | 1,406 | Jun 15, 2025 |
| Yocca Frank | Chief Scientific Officer | Option Exercise | 33 | — | — | 1,906 | Jun 15, 2025 |
| Mehta Vimal | CEO and President | Option Exercise | 163 | — | — | 4,267 | Jun 15, 2025 |
| Rodriguez Javier | See Remarks | Option Exercise | 33 | — | — | 1,624 | Jun 15, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 11,851 | May 31, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 10,158 | Apr 30, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 8,465 | Mar 31, 2025 |
| Yocca Frank | Chief Scientific Officer | Option Exercise | 31 | — | — | 1,839 | Mar 15, 2025 |
| Mehta Vimal | CEO and President | Option Exercise | 162 | — | — | 3,887 | Mar 15, 2025 |
| Steinhart Richard I | Chief Financial Officer | Option Exercise | 34 | — | — | 1,373 | Mar 14, 2025 |
| Rodriguez Javier | See Remarks | Option Exercise | 34 | — | — | 1,591 | Mar 14, 2025 |
| MACK DAVID J. | — | Option Exercise | 1,693 | — | — | 6,772 | Feb 28, 2025 |
| MACK DAVID J. | — | Option Exercise | 27,089 | — | — | 81,267 | Jan 31, 2025 |
| MACK DAVID J. | — | Option Exercise | 27,089 | — | — | 54,178 | Dec 31, 2024 |
| O'Neill Vincent | See Remarks | Option Exercise | 521 | — | — | 20,122 | Dec 16, 2024 |
| Steinhart Richard I | Chief Financial Officer | Sale | 372 | $0.36 | $134 | 20,932 | Dec 15, 2024 |
| Mehta Vimal | CEO and President | Option Exercise | 3,500 | — | — | 61,903 | Dec 14, 2024 |
| Rodriguez Javier | See Remarks | Option Exercise | 562 | — | — | 24,853 | Dec 14, 2024 |
| Yocca Frank | Chief Scientific Officer | Sale | 225 | $0.35 | $79 | 28,931 | Dec 14, 2024 |
| MACK DAVID J. | — | Option Exercise | 27,089 | — | — | 27,089 | Nov 30, 2024 |
| MACK DAVID J. | — | Option Exercise | 27,089 | — | — | 27,089 | Nov 30, 2024 |
| Rodriguez Javier | See Remarks | Award / Grant | 21,250 | — | — | 30,633 | Oct 3, 2024 |
| Steinhart Richard I | Chief Financial Officer | Award / Grant | 21,250 | — | — | 27,454 | Oct 3, 2024 |
| Wiley Matthew T. | Chief Commercial Officer | Sale | 6,272 | $0.55 | $3,450 | 19,011 | Sep 17, 2024 |
| Yocca Frank | Chief Scientific Officer | Sale | 7,175 | $0.55 | $3,946 | 28,278 | Sep 17, 2024 |
| O'Neill Vincent | See Remarks | Sale | 5,556 | $0.55 | $3,056 | 19,601 | Sep 17, 2024 |
| O'Neill Vincent | See Remarks | Option Exercise | 521 | — | — | 4,045 | Sep 16, 2024 |
| Rodriguez Javier | See Remarks | Option Exercise | 521 | — | — | 8,915 | Sep 15, 2024 |
| Wiley Matthew T. | Chief Commercial Officer | Sale | 215 | $0.69 | $148 | 4,033 | Sep 15, 2024 |
| Yocca Frank | Chief Scientific Officer | Option Exercise | 563 | — | — | 14,558 | Sep 14, 2024 |
| Mehta Vimal | CEO and President | Sale | 1,150 | $0.69 | $793 | 51,666 | Sep 14, 2024 |
| Steinhart Richard I | Chief Financial Officer | Sale | 356 | $0.69 | $246 | 6,204 | Sep 14, 2024 |
| Wiley Matthew T. | Chief Commercial Officer | Option Exercise | 750 | — | — | 3,742 | Jun 17, 2024 |